Harrogate District Hospital

Harrogate HG2 7SX

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, MF, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy — Completed